These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36418349)

  • 1. Dose-response meta-analysis on urate, gout, and the risk for Parkinson's disease.
    Chang H; Wang B; Shi Y; Zhu R
    NPJ Parkinsons Dis; 2022 Nov; 8(1):160. PubMed ID: 36418349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum urate and the risk of Parkinson's disease: results from a meta-analysis.
    Shen C; Guo Y; Luo W; Lin C; Ding M
    Can J Neurol Sci; 2013 Jan; 40(1):73-9. PubMed ID: 23250131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uricosuric medications for chronic gout.
    Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urate and the risk of Parkinson's disease in men and women.
    Cortese M; Riise T; Engeland A; Ascherio A; Bjørnevik K
    Parkinsonism Relat Disord; 2018 Jul; 52():76-82. PubMed ID: 29615298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The benchmark dose estimation of reference levels of serum urate for gout.
    Chen X; Wang Z; Duan N; Cui W; Ding X; Jin T
    Clin Rheumatol; 2018 Oct; 37(10):2887-2891. PubMed ID: 30145637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis.
    Dalbeth N; Phipps-Green A; Frampton C; Neogi T; Taylor WJ; Merriman TR
    Ann Rheum Dis; 2018 Jul; 77(7):1048-1052. PubMed ID: 29463518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory rheumatic diseases and the risk of Parkinson's disease: A systematic review and meta-analysis.
    He L; Zhao H; Wang F; Guo X
    Front Neurol; 2022; 13():999820. PubMed ID: 36438950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between gout and the development of Parkinson's disease: a systematic review and meta-analysis.
    Fazlollahi A; Zahmatyar M; Alizadeh H; Noori M; Jafari N; Nejadghaderi SA; Sullman MJM; Gharagozli K; Kolahi AA; Safiri S
    BMC Neurol; 2022 Oct; 22(1):383. PubMed ID: 36221048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Higher Serum Lipid Levels on the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Jiang Z; Xu X; Gu X; Ou R; Luo X; Shang H; Song W
    Front Neurol; 2020; 11():597. PubMed ID: 32670190
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of Parkinson's disease in a gout Mediterranean population: A case-control study.
    Pou MA; Orfila F; Pagonabarraga J; Ferrer-Moret S; Corominas H; Diaz-Torne C
    Joint Bone Spine; 2022 Nov; 89(6):105402. PubMed ID: 35504516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for tophi in gout.
    Sriranganathan MK; Vinik O; Bombardier C; Edwards CJ
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010069. PubMed ID: 25330136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of plasma urate and risk of Parkinson disease in men and women.
    Gao X; O'Reilly ÉJ; Schwarzschild MA; Ascherio A
    Neurology; 2016 Feb; 86(6):520-6. PubMed ID: 26764029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One year safety and efficacy of inosine to increase the serum urate level for patients with Parkinson's disease in Japan.
    Iwaki H; Ando R; Miyaue N; Tada S; Tsujii T; Yabe H; Nishikawa N; Nagai M; Nomoto M
    J Neurol Sci; 2017 Dec; 383():75-78. PubMed ID: 29246629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief Report: Monosodium Urate Monohydrate Crystal Deposits Are Common in Asymptomatic Sons of Patients With Gout: The Sons of Gout Study.
    Abhishek A; Courtney P; Jenkins W; Sandoval-Plata G; Jones AC; Zhang W; Doherty M
    Arthritis Rheumatol; 2018 Nov; 70(11):1847-1852. PubMed ID: 29806203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global patterns of treat-to-serum urate target care for gout: Systematic review and meta-analysis.
    Son CN; Stewart S; Su I; Mihov B; Gamble G; Dalbeth N
    Semin Arthritis Rheum; 2021 Aug; 51(4):677-684. PubMed ID: 34139520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gout is not associated with a lower risk of Parkinson's disease: A systematic review and meta-analysis.
    Ungprasert P; Srivali N; Thongprayoon C
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1238-42. PubMed ID: 26330027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and Parkinson's disease risk in women: a meta-analysis of 14 observational studies.
    Wang P; Li J; Qiu S; Wen H; Du J
    Neuropsychiatr Dis Treat; 2015; 11():59-66. PubMed ID: 25657580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular events in hyperuricemia population and a cardiovascular benefit-risk assessment of urate-lowering therapies: a systematic review and meta-analysis.
    Zhao L; Cao L; Zhao TY; Yang X; Zhu XX; Zou HJ; Wan WG; Xue Y
    Chin Med J (Engl); 2020 Apr; 133(8):982-993. PubMed ID: 32106120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gout is not associated with the risk of fracture: a meta-analysis.
    Liu F; Dong J; Zhou D; Kang Q; Xiong F
    J Orthop Surg Res; 2019 Aug; 14(1):272. PubMed ID: 31455330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diet, urate, and Parkinson's disease risk in men.
    Gao X; Chen H; Choi HK; Curhan G; Schwarzschild MA; Ascherio A
    Am J Epidemiol; 2008 Apr; 167(7):831-8. PubMed ID: 18326873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.